Tag archive for ‘Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ)’
Efrat Peretz On Sunday, August 17th, 2014

Novartis to invest heavily in Gamida Cell

– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. –   The deal for the sale of Gamida Cell developer of a stem-cell treatment for blood cancer, More...

Ilan Shavit On Tuesday, March 18th, 2014

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell

– The stem cell developer could be acquired at a company value of hundreds of millions of dollars. – Stem cell therapies developer Gamida-Cell Ltd. has received an acquisition offer from an international pharma More...

Wordpress site Developed by Fixing WordPress Problems